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Abstract: Cecropia glaziovi Snethl., Urticaceae, is commonly used in South America 
and is one of the species included in the Brazilian Medicinal Plants Research Program. 
Pharmacological studies have led to reports of the potential of C. glaziovi as a hypotensive, 
antiasthmatic and anxiolytic agent. The strict requirements regarding the quality, safety 
and effectiveness of phytopharmaceutical products represent an enormous challenge in 
the search for products with a high level of uniformity, reproducibility and stability. The 
incorporation of dry extracts into multiparticulate dosage forms, such as pellets produced 
by extrusion/spheronization technology, is a suitable alternative to overcome the lack of 
technological properties of dry extracts, since they are associated with low fl owability 
and high hygroscopicity. In this study, an optimized dry extract (ODE) of C. glaziovi 
was incorporated into pellets seeking to decrease the moisture sorption and increase 
the stability, safety and percentage of the extract in the fi nal product. Pellets containing 
around 50% of ODE were considered the most technologically viable, offering a narrow 
particle size distribution, signifi cant improvement in the fl owability and compressibility 
properties, and decrease in the moisture compared with the ODE. In conclusion, pellets 
containing a high dose of the C. glaviovi extract were successfully prepared, achieving 
degrees of quality, physical stability and feasibility compatible with the desirable 








 Herbal extracts are widely used to treat diseases 
in Traditional Brazilian Medicine. However, strict 
regulatory requirements in relation to the quality, safety 
and effectiveness of phytopharmaceuticals (Anvisa, 2010) 
result in signifi cant challenges being associated with 
the search for products with a high level of uniformity, 
reproducibility and stability. Although dry herbal extracts 
are more stable in comparison to their aqueous form, they 
have a complex composition and contain a number of active 
components and hydrophilic ingredients with a tendency to 
absorb moisture leading to microbial growth and hydrolysis 
(Fischer, 2007). The highly hydrophilic characteristic of 
these compounds may facilitate the production of highly 
concentrated herbal extracts in aqueous and hydroalcoholic 
solutions. On the other hand, this characteristic also 
presents a challenge due to the signifi cant effects on the 
physicochemical and technological properties as well as 
the biopharmaceutical properties of the extracts (Emery et 
al., 2009).
 Cecropia glaziovi Snethl., Urticaceae, is a vegetal 
species commonly used by the South American population 
for anti-hyperlipidemic purposes (Silva et al., 2010). 
Several pharmacological studies have been reported in the 
past few years indicating the potential of C. glaziovi as 
a hypotensive (Ninahuaman et al., 2007), antiasthmatic 
(Delarcina Jr. et al., 2007) and anxiolytic (Rocha et al., 
2002) vegetal drug. In preliminary studies conducted by our 
group, the presence of high amounts of both chlorogenic 
and caffeic acids were observed in hydroalcoholic extracts 
prepared with the leaves of C. glaziovi, which prompted 
the development and validation of an analytical method 
for the quantifi cation of these chemical markers (Arend et 
al, 2011).
 C. glaziovi is one of the species included in the 
Brazilian Medicinal Plants Research Program (Brasil, 
2006), but the authors could fi nd no reports available 
on studies related to the technological issues associated 
with the preparation of solid dosage forms containing C. 
glaziovi extract. 
 Oral solid dosage forms, such as tablets and 
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capsules, containing dry herbal extracts have proved to 
be a suitable alternative for the use of medicinal herbs. 
However, the production of this type of dosage form 
requires the use of several adjuvants and additional 
operations due to the poor technological properties of the 
crude dry extracts, such as low flowability and density 
and high hygroscopicity (List & Schmidt, 1989; Petrovick 
et al., 2010; Sonaglio et al., 2010). The incorporation of 
dry extracts into granulated dosage forms is a suitable 
alternative to overcome such issues (List & Schmidt, 1989, 
Sonaglio et al., 2010). Pellets as a multiparticulate drug 
delivery system offer several technological and therapeutic 
advantages since they consist of a “multiple unit” dosage 
form with defined diameter of 0.5-2 mm and minimum 
surface/volume ratio, which ensures a good drug dissolution 
rate, less irritation of the gastro-intestinal tract and lower 
risk of side effects (Aguilar-de-Leyva et al., 2011). From 
the technological point of view, some characteristics of 
pellets, such as free flow properties, narrow particle size 
distribution and ideal surface for coating qualify them as 
a good solid dosage form (Chopra et al., 2002, Koester 
& Thommes, 2010, Sousa et al., 2002). In addition, this 
dosage form is appropriate to increase the amount of 
the active component in the formulation due to its high 
density (Di Pretoro et al., 2010), while the administration 
of a low density crude extract may become an issue when 
high amounts of herbal extract are necessary to achieve the 
therapeutic concentration of the active compounds.
 Among several technologies available for 
pelletization, the extrusion-spheronization method (Kanbe 
et al., 2007) is one of the most commonly used. This method 
requires the preparation of a plastic mass by heating or 
moistening with a specific granulation liquid, shaping the 
wet mass into cylinders through extrusion, rounding the 
extrudates into spheres and drying the final product. Some 
properties of the raw materials have a strong influence on 
the quality of the pellets produced requiring formulation 
studies in order to determine the ideal formulation for 
extrusion-spheronization. Good wettability, ability to bind 
moisture, plastic behavior, good lubricity, and ability of 
the extruded material to separate are some of the important 
factors required of the raw materials used in pelletization 
(Kanbe et al., 2007).
 In this study, a standardized Optimized Dry 
Extract (ODE) of C. glaziovi was incorporated into pellets 
as a solid oral dosage form in order to decrease the moisture 




 Chemical reagents and other materials were 
obtained from the following commercial sources: 
chlorogenic acid and caffeic acid (Sigma-Aldrich, St. 
Louis, MO, USA), methanol and acetonitrile (HPLC grade) 
(J.T. Baker, Phillipsburg, NJ, USA), acetic acid (Qhemis, 
São Paulo, Brazil), LC grade water obtained with a Milli-Q 
system (Millipore, Bedford, MA, USA), and ethanol 
(Labsynth, São Paulo, Brazil). Microcrystalline cellulose 
101 (Microcel® 101) and polyvinylpyrrolidone (Kollidon® 
VA64-Fine) were kindly donated by Blanver (São Paulo, 
Brazil) and BASF (São Paulo, Brazil) respectively. All 
samples and solutions were prepared with purified water. 
All other reagents and solvents were analytical grade.
Plant material
 Dried leaves of Cecropia glaziovi Snethl., 
Urticaceae, were obtained from the Pluridisciplinary 
Center of Chemical, Biological and Agronomic Studies 
(CPQBA) of the University of Campinas (UNICAMP) 
in Campinas, São Paulo, Brazil. A specimen voucher is 
deposited at the CPQBA herbarium under number 78. 
The dried leaves were ground in a knife mill (Macmont) 
using a 3 mm mesh. The milled vegetal material was 
characterized according to the particle size distribution, 
loss on drying and total ash as described below.
Vegetal drug characterization 
 The particle size distribution of the vegetal 
drug was evaluated by a standard sieving method, for 
a period of 15 min (Sieve Shaker Bertel 1400), with 
30 g of the dried milled plant material, using a series 
of sieves with screen sizes corresponding to 180, 355, 
500, 710, 1000 and 1700 μm. The average particle 
size was calculated by means of Probito’s evaluation 
(Pasqualoto et al., 2005; Vila-Jato, 1997).
 Loss on drying (LOD) analysis was carried 
out in order to determine the amount of water and 
volatile matter in the vegetal drug material. The LOD 
was determined gravimetrically by weighing 1.0 g of 
milled leaves in an aluminum plate and submitting the 
samples to a heat-generating halogen analyzer (MB35 
Ohaus) at 105 ºC until the weight reading stabilized. 
The results were expressed as percentage weight loss 
(w/w) considering the mean of three measurements (F. 
Bras. V, 2010).
 The total ash (TA) content was determined after 
ignition of the milled leaves. This analysis was carried 
out gravimetrically by weighing 3.0 g of milled leaves 
in a porcelain crucible. The samples were submitted to 
calcination in an oven at 600 °C for 2 h. The results 
were expressed as percentage of the remaining weight 
(w/w) considering the mean of three measurements (F. 
Bras. V, 2010).
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Preparation and characterization of the optimized dry 
extract (ODE)
 The liquid hydroalcoholic extract was prepared 
according to previously optimized conditions (Dos Santos, 
2012). The ground vegetal material was macerated at room 
temperature for three days. This operation was carried out 
in glass bottles with 18:100 (w/v) vegetal drug:27°GL 
ethanol solution ratio.
 The optimized liquid extract (density 0.9504 g/
mL) was concentrated under vacuum at 40 oC (MA-120, 
Marconi, Brazil) and freeze-dried for 48 h (LD1500, 
Terroni), obtaining as result the optimized dry extract 
(ODE).
 The ODE was characterized according to the 
chlorogenic (CGA) and caffeic (CFA) acids contents and 
the Hausner and Carr indexes as described below.
Pellets formulation
 Pellets were prepared by the extrusion-
spheronization technique. Defined amounts of ODE 
were blended with microcrystalline cellulose 101 
(MCC) achieving proportions of 20:80, 35:65 and 50:50 
(MCC:ODE). The granulation liquid was water or 
polyvinylpyrrolidone (PVP) aqueous solution according 
to the need for binding agents. The amount of granulation 
liquid and concentration of PVP solution (0, 2 or 5%) 
required were determined experimentally.
 The wet mass was transferred to a screen extruder 
(Extruder 20, Caleva Ltd.) and immediately extruded 
through a perforated screen of 1.0 mm diameter at a 
constant speed of 16 rpm.
 The extrudates were transferred to a spheronizer 
(Spheronizer 120, Caleva Ltd.) equipped with a 3.0 mm 
square pitch cross-hatched friction plate and spheronized 
for 1 min at 1000 rpm. After complete spheronization, 
pellets were left to dry on a fluid bed (Mycrolab, Huttlin 
Ltd.) for 15 min (batch size 100 g; air flow 15 m3/h; inlet 
air temperature 60 ºC).
 The particle size distribution of every formulation 
was carried out by a standard sieving method, for a period 
of 15 min (Sieve Shaker Bertel 1400), with 30 g of pellets, 
using a series of sieves with screen sizes corresponding 
to 180, 355, 500, 710, 800, 900, 1000, 1120, 1180, 1250, 
1500 and 1700 μm.
Quantitative analysis
 The chromatographic analysis was performed 
using a previously validated method (Arend et al., 2011) 
on a PerkinElmer high-pressure chromatograph equipped 
with a Series 200 auto sampler, Series 200 binary pump, 
Series 200 UV-Vis detector or Series 200 EP Diode Array 
Detector and Series 200 vacuum degasser. A Zorbax 
C HP C18 column (5 mm, 150 mm × 4.6 mm, Agilent 
Technologies) was used. The mobile phase consisted of 
acetonitrile (A) and 1.0% acetic acid (B) with a flow rate 
of 1 mL/min and was programmed as follows: 0-15 min, 
isocratic, 87% B; 15-25 min, gradient, 87-60% B; 25-34 
min, isocratic, 60% B. Detection was set at 330 nm. The 
injection volume was 20 μL. The data were collected using 
TotalChrom® Workstation software. 
 The quantification of the chemical markers 
was carried out by comparison of their retention times 
and by coinjection of the standard solutions. Standard 
curves were plotted for chlorogenic (2.5-200 μg/mL) and 
caffeic (2.5-100 μg/mL) acids. The quantification of the 
individual compounds was performed using a validated 
regression curve (r2>0.9999). For the quantification of the 
dry extract, a known amount was dissolved in 10 mL of a 
methanol:water solution (50:50; v/v). 
In order to obtain the pellets sample, a known amount 
of these was triturated and left under magnetic stirring 
in 50 mL of a methanol:water solution (50:50; v/v). The 
suspension was centrifuged (4K15, Sigma) at 1500 rpm 
for 5 min and the supernatant was collected for analysis.
 The samples were filtered through a 0.45 mm 
HVLP membrane (Millipore) before injection. All of the 
chromatographic analysis was performed in triplicate and 
the average areas of the peaks were calculated.
Hausner and Carr indexes and aspect ratio
 A 100 mL cylinder was filled with pellets of a 
known total weight and the mass to volume ratio of the 
pellets was calculated in order to determine the bulk 
density (ρb) of the pellets. The same samples were placed 
in a tapped density tester (Copley JV 1000) in order to 
compress the content. After 300 taps or when the volume 
remained constant, the mass to volume ratio of the 
compressed pellets was calculated in order to determine 
the tapped density (ρt).
 The Hausner Index (HI) (Emery et al., 2009; 
Hausner, 1967; Soares et al., 2005), used as indicative of 
the packing capacity of powders and granules, was then 
calculated according to the following equation:
   HI=ρt/ρb
 The Carr Index (CI) (Carr, 1965; Emery et 
al., 2009; Soares et al., 2005), considered indicative of 
flowability, was calculated according to the following 
equation:
  CI (%)=[(ρt-ρb)/ρt]*100
 For comparison, the ODE was also characterized 
by the HI and CI as described above. Micrographs of 
pellets were taken using a Stereo-microscope coupled to 
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a photographic camera (Olympus SZ 40). The aspect ratio 
(AR) of the pellets was determined by image analysis (Size 
Meter 1.1, LCP, UFSC) as the ratio between the longest 
caliper distance and the caliper distance perpendicular to 
it.
Scanning electron microscopy (SEM)
 Scanning electron microscopy (SEM) analysis 
of all samples was carried out on a Philips XL-30 
scanning electron microscope. The samples were coated 
with a fine gold layer before analysis. All samples were 
analyzed using an accelerating voltage of 10.0 kV and the 
magnification of images was set at 60x and 300x for C. 
glaziovi pellets and ODE, respectively.
Moisture content of pellets and ODE 
 The residual moisture content of the pellets and 
ODE was determined by a loss-on-drying method (F. 
Bras. V, 2010) using a halogen moisture analyzer (MB35 
Ohaus). Approximately 1 g of material was deposited in an 
aluminum plate and dried at 105 ºC under a heat-generating 
halogen source until the weight reading stabilized. The 
moisture content was expressed in percentage terms (%; 
w/w) as the mean of three measurements.
 The capacity to gain moisture was determined 
through a controlled-humidity micro-environment 
exposure method (Hong et al., 2005). Samples of C. 
glaziovi pellets and ODE were sealed in a glass desiccator, 
containing a saturated solution of sodium chloride, at room 
temperature. This solution is capable of maintaining the 
relative humidity at 75% in a temperature range of 20 to 
40 ºC inside sealed enclosures (Hong et al., 2005; O'Brien, 
1948). The relative humidity was monitored daily using 
a calibrated hygrometer and the maximum variation was 
only 1% at room temperature (25±2ºC) during the whole 
experiment. The samples were analyzed at 15 and 30 
days of exposure using a halogen moisture analyzer in 
order to determine the moisture gain potential of both the 
pellets and ODE. The results were expressed in percentage 
terms (%; w/w) as the mean of three measurements. 
Photographic images of the ODE and pellets before and 
after the moisture content study were obtained using a 
Fujifilm Finepix HS20EXR high-definition camera.
Results and discussion
Vegetal drug characterization 
 It is known that an excess of humidity enhances 
the enzymatic degradation of the chemical constituents 
of vegetal drug material during storage and allows the 
proliferation of micro-organisms (Fischer, 2007). In this 
study the volatile matter, including the humidity content, 
was determined through the LOD and the value found 
(13.10±0.44%) was considered to be satisfactory, according 
to the Brazilian Pharmacopoeia (F. Bras. V, 2010). The 
mean diameter of the crushed leaves was 0.946±0.798 mm 
and this is valuable information for the standardization 
since the reproducibility of the extractive process has a 
direct relation with the access of the extraction solvent 
to the vegetal material surface. The TA content was 
considered indicative of the degree to which the vegetal 
material could be considered as ‘clean’ (Fischer, 2007) and 
the value found (7.92±0.33%) was satisfactory (F. Bras. V, 
2010).
Pellets formulation
 The formulations were prepared in the order 
shown in the Table 1 by the extrusion-spheronization 
method. The amount of water added to the powder mixture 
of MCC and ODE was determined experimentally until the 
mass was sufficiently moist for extrusion.
 The use of water as granulation liquid aimed 
to simulate the possibility of direct incorporation of the 
aqueous extract, without prior drying, reducing the number 
of production stages (concentration and drying of extract), 
optimizing time and cost in production.
Table 1. Viability for extrusion-spheronization and yield of 
usable fraction (0.5-1.0 mm) for the pellets formulations.
Formulation Water (g)
PVP 





FM1 31.2 - 20:80 NV -
FM2 46.9 - 35:65 NV -
FM3 65.3 - 50:50 + 54.9%
FM4 66.2 2% 50:50 +++ 68.2%
FM5 65.8 5% 50:50 ++++ 89.4%
*Viability: NV=not viable; +=slightly viable; +++=viable; ++++=highly 
viable.
 The FM1 contained the highest amount of ODE in 
its composition, aimed at the incorporation of the maximum 
content of extract. Nevertheless, this formulation was not 
viable since the high amount of hydrophilic extract led 
to the formation of a goo due to the mucilage nature of 
the ODE (Lobova et al., 2003; Ribeiro & Mors, 1950). In 
comparison to other formulations, FM1 needed the lowest 
content of water (31.2 g) in order to achieve the necessary 
humidity for extrusion, but the tacky extrudates formed 
were inclined to agglomerate during spheronization 
hindering the formation of spherical granules.
 A similar behavior to that shown by FM1 was 
observed for FM2, which contained a 35:65 MCC:ODE 
ratio. Although a higher amount of MCC was used, the 
high concentration of ODE also induced the formation of 
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tacky extrudates with a tendency towards agglomeration 
during spheronization. The behavior observed in both 
formulations is related to the attempt to incorporate a large 
amount of extract in comparison to FM3 (Table 1). These 
formulations contained no PVP in its constitution, even 
so a slight viability on production was achieved when 
ODE’s concentration was reduced to 50% (FM3). The 
attempt of avoiding the inclusion of additional polymeric 
excipients, such as PVP, was based on the fact that pellets 
with acceptable physical characteristics may be produced 
using only water as granulation liquid (Sonaglio et al., 
2012). Moreover, the addition of polymeric excipients 
may interfere on the biopharmaceutical characteristics of 
the final product (Kalivoda et al., 2012). 
 Although FM3 was viable for the formation of 
granules with acceptable spherical shape, it was verified 
that the particle size distribution was too broad, with the 
formation of high amounts of fines. Table 1 shows the 
amount of pellets within the usable fraction of 0.5-1.0 mm 
determined in this study for comparison purposes.
 In order to decrease the amount of fine particles, 
two concentrations of PVP solution (2 and 5%; FM4 and 
FM5, respectively) were added. The use of hydrophilic 
polymers, such as PVP, is an interesting strategy to 
improve the extrusion-spheronization process since they 
are capable to form solid bridges enhancing the cohesion 
of the wet mass. The use of PVP as a spheronization aid 
usually leads to higher yield and improvement on the 
sphericity of the particles (Law & Deasy, 1998; Otero-
Espinar et al., 2010). As expected for these formulations, 
an improvement in the plasticity and cohesion of the wet 
mass was observed, and a narrow particle size distribution 
of pellets was achieved. The amount of granulation liquid 
was kept constant since the moisture content required for 
extrusion had already been reached. Both FM4 and FM5 
presented significant improvement in this regard and FM5 
was considered the most viable formulation. Thus, batches 
of FM5 were produced in high quantity in order to proceed 
with the C. glaziovi pellet characterization. 
Quantitative analysis 
 The chemical markers chosen for the quantitative 
evaluation of the extracts were CFA and CGA, for which 
the analytical methodology was previously validated 
(Arend et al., 2011). Besides these chemical markers, 
another two polyphenolic compounds-isovitexin (ISV) 
and isoorientin (ISR)-with established pharmacological 
activity as hypoglycemic agents (Andrade-Cetto & 
Wiedenfeld, 2001: Folador et al., 2010) were identified in 
the chromatogram shown in Figure 1.
 FM5 pellets and ODE were characterized 
according to their CGA and CFA contents. Contents of the 
ODE chemical markers were determined as 87.80±0.75 
μg/g for CGA and 32.13±0.27 μg/g for CFA. The contents 
in FM5 were determined as 42.08±0.02 μg/g for CGA and 
14.92±0.01 μg/g for CFA.
 
Figure 1. Typical UV chromatogram of the crude extract 
of Cecropia glaziovi and corresponding peaks of chemical 
markers.
Hausner and Carr indexes and aspect ratio
 The Hausner (HI) and Carr (CI) indexes are 
indicators of the powder flowability and compressibility 
properties (Carr, 1965; Chopra et al., 2002; Emery et al., 
2009; Hausner, 1967; Soares et al., 2005). HI and CI values 
lower than 1.20 and 15%, respectively, are considered 
satisfactory. 
Table 2. Hausner and Carr indexes and aspect ratio for ODE and 
FM5.
ρb (g/cm3) ρt (g/cm3) HI CI (%) AR
ODE 0.523±0.012 0.684±0.003 1.30±0,03 23.33±1.53 -
FM5 0.693±0.009 0.710±0.003 1.02±0.02 2.34±0.71 0.91±0.07
 
 On comparing the HI and CI values, an enormous 
improvement in the technological properties of ODE was 
verified after incorporation into the pellets. The results 
obtained for the FM5 pellets of C. glaziovi were considered 
satisfactory for all indexes analyzed (Table 2). The ODE 
have a very small and irregular particle size (Figure 2), 
which produces a material with poor flow properties 
inherent to the high cohesiveness between particles. This 
behavior can adversely affect the content uniformity in the 
production of dosage forms, which leads to the need to 
incorporate poorly flowing powders, such as the ODE, into 
more elaborate intermediate dosage forms like pellets. The 
results obtained indicated excellent compressibility and 
flow properties for the FM5 pellet formulation (Aguilar-
de-Leyva et al., 2011; Chopra et al., 2002). Good flow 
is important in the production of capsules and tablets, 
where satisfactory filling and content uniformity is 
necessary (Podczeck et al., 2008). The achievement of a 
technologically viable phytopharmaceutical product with 
good flow properties is important since this dispenses the 
need to introduce additional excipients, such as lubricants, 
which could modify the dissolution rate of the herbal 
extract. Moreover, the improvement of the technological 
properties allows a maximum drug per unit volume since 
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it would not be necessary the addition of high amounts (or 
no addition at all) of excipients in order to produce tablets 
or capsules. When it comes to the production of these final 
dosage forms using the crude ODE, the final concentration 
of the product would be diluted since the addition of high 
amounts of excipients is necessary in order to overcome 
ODE’s lack of technological properties. These results have 
considerable impact when a high drug dose is required, 
as commonly needed in the case of treatments with 
phytopharmaceuticals.
 The aspect ratio (AR) of 0.91 (Table 2) can be 
considered satisfactory indicating that the pellets produced 
are acceptably spherical. Chopra et al. (2002) demonstrated 
that there is an important correlation between the amount 
of under-filled capsules and the pellet shape. The pellets 
do not necessarily need to be totally spherical to provide 
good filling results, but an increase in friction due to non-
spherical shape and thus a more pronounced sensitivity to 
electrostatic charging can result from increased surface 
roughness and, consequently, influence the filling ability 
of the product.
Scanning electron microscopy (SEM) 
 Scanning electron microscopy (SEM) was also 
used to visualize the pellet surface morphology. Based on 
the photomicrographs, spherical and slightly rough beads 
without cracks were obtained (Figure 2). The comparison 
of the slight roughness of the pellets to the surface of the 
small non-regular-shaped particles of the ODE (Figure 2) 
indicates a significant improvement from the technological 
point of view, since the pellets flow properties appear to be 
a function of the surface roughness (Chopra et al., 2002).
 These results indicate that the pellets obtained 
are suitable for its use as intermediate on the production 
of final solid dosage forms (e.g. capsules, tablets), due 
to their adequate flow and compressibility indexes and 
slightly rough surface.
Moisture content of pellets and ODE 
 One of the main difficulties associated with the 
use of dry herbal extracts is their high hygroscopicity. 
The moisture sorption can exert significant effects on 
the physicochemical and technological properties of the 
dry extracts. An improvement in the moisture resistance 
is desirable since the high hygroscopicity is one of the 
most critical issues in terms of the industrial production of 
phytopharmaceuticals. In relation to technological issues, 
an excess of moisture may decrease the ability of powders 
and granules to flow smoothly since the increased tackiness 
of the absorbed moisture layer increases the strength of 
liquid bridges formed between particles (Emery et al., 
2009). In this regard, pelletization has the potential to 
improve this aspect, since the moisture sorption has much 
higher technological impact on small-particle products 
such as ODE in comparison to large particles, as in the 
case of pellets. The amount of water absorbed by pellets 
needs to be a lot higher in order to significantly influence 
the flow properties.
 The moisture sorption is also a pharmacological 
issue since it accelerates the enzymatic degradation of 
chemical constituents, compromising the biological 
activity, and may also enhance the development of 
microorganisms decreasing the expiration time of the final 
product (Fischer, 2007). 
Table 3. Percentage of water gain (w/w) of ODE and FM5 after 
15 and 30 days.
Percentage of water gain
Time zero After 15 days After 30 days
ODE 3.30±0.11 24.78±0.17 36.76±0.98
FM5 2.51±0.15 14.11±0.96 18.65±0.20
 
 In relation to the water gain for ODE and FM5 
(Table 3), in both cases an increase in moisture content 
Figure 2. SEM of (a) Cecropia glaziovi pellet surface (60x) and (b) ODE particles (300x).
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was observed, however, the behavior differed. In the case 
of ODE, there was an important moisture increase for both 
periods evaluated, that is, 15 and 30 days, whereas for 
FM5, this increase was significantly lower, around half that 
observed for ODE (Table 3). In comparison with the crude 
ODE, the moisture resistance of the ODE incorporated into 
the pellets dosage form was clearly improved. In addition, 
the incorporation of ODE in pellets avoided the loss of the 
original structure after moisture sorption, such as noted in 
crude extract. This is evident in Figure 3, where there is the 
formation of a goo for the ODE, while the pellets presented 
only a slight change of color. This study showed that even 
though MCC has a known ability to retain water (Tomer 
et al., 2001), the incorporation of extremely hydrophilic 
dry extracts such as ODE into an MCC matrix exerts a 
beneficial effect in terms of decreasing moisture sorption. 
Along with this improvement in the moisture resistance 
achieved by pelletization, the water gain could be further 
enhanced by other technological resources, such as a 
polymeric coating.
 Conclusions 
 Formulation variables were studied in order to 
determine the ideal parameters to produce pellets of a 
Cecropia glaziovi Snethl., Urticaceae, extract by extrusion-
spheronization. Different proportions of extract were 
blended with MCC in order to incorporate the maximum 
content of ODE. It was verified that the 50:50 ratio using as a 
binder a 5% PVP solution led to the production of spherical 
granules with adequate technological characteristics. 
The flowability and compressibility of the optimized 
formulation was suitable. This formulation could be used 
as an intermediate dosage form to fill capsules or to be 
compressed into tablets. Moreover, it was verified that the 
incorporation of ODE into pellets increased significantly 
the moisture resistance enhancing the physical stability of 
the product.
 In conclusion, pellets containing C. glaviovi 
extract were successfully prepared, achieving a degree 
of quality, physical stability and feasibility compatible 
with the characteristics required for the production of a 
phytopharmaceutical product. 
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